BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/8/2026 9:37:26 AM | Browse: 6 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Icariin inhibits tumor-associated neutrophil recruitment via the CXCL8-CXCR2 axis and restrains pro-metastatic programs in colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan-Hua Zhao, Juan Chen, Tao Gong, Hai-Yan Ge and Min Li |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Min Li, PhD, Department of Oncology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, No. 157 Daming Road, Nanjing 210022, Jiangsu Province, China. limin_2024@163.com |
| Key Words |
Icariin; Neutrophils; Recruitment; C-X-C motif chemokine ligand 8-C-X-C motif chemokine receptor 2 axis; Colorectal cancer; Pro-metastatic program; Progression |
| Core Tip |
This study elucidates a novel mechanism by which the natural compound icariin (ICA) combats colorectal cancer. We demonstrate that ICA upregulates the tumor suppressor SMAD4, thereby inhibiting the production of C-X-C motif chemokine ligand 8 (CXCL8) and other C-X-C motif chemokine receptor 2 (CXCR2)-associated chemokines. This action predominantly limits the recruitment of tumor-associated neutrophils (TANs) via the CXCL8-CXCR2 axis. Notably, ICA not only reduces neutrophil infiltration but also reprograms TANs toward an antitumor N1 phenotype. By disrupting this SMAD4-CXCL8-CXCR2-TAN axis, ICA effectively restrains epithelial-mesenchymal transition and other pro-metastatic processes, positioning it as a promising therapeutic candidate with a distinct immunomodulatory strategy against colorectal cancer progression. |
| Citation |
Zhao YH, Chen J, Gong T, Ge HY, Li M. Icariin inhibits tumor-associated neutrophil recruitment via the CXCL8-CXCR2 axis and restrains pro-metastatic programs in colorectal cancer. World J Gastroenterol 2026; In press |
 |
Received |
|
2025-09-23 09:00 |
 |
Peer-Review Started |
|
2025-09-23 09:00 |
 |
First Decision by Editorial Office Director |
|
2025-10-17 06:19 |
 |
Return for Revision |
|
2025-10-17 06:19 |
 |
Revised |
|
2025-11-16 07:43 |
 |
Publication Fee Transferred |
|
2025-11-28 05:50 |
 |
Second Decision by Editor |
|
2026-01-08 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-01-08 09:37 |
 |
Articles in Press |
|
2026-01-08 09:37 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345